| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |